A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia

NCT02690714 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Prometic Biotherapeutics, Inc.